Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)

Miquel Beltràn, Ramon Colomer, Allan Lipton, S. M. Ali, K. Leitzel

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)4605-4606
Number of pages2
JournalJournal of Clinical Oncology
Issue number23
StatePublished - Dec 1 2002

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this